ADAR1 Capital Management, LLC

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 27% 8.2% 15.1%
Success rate 96% 68% 82%
Transactions
39 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ADAR1 Capital Management, LLC's trades of Tenax Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.80
Quantity 8,003 +1.1%
Value US$38,414
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.98
Quantity 25,000 +3.6%
Value US$124,540
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.98
Quantity 3,300 +0.5%
Value US$16,420
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.96
Quantity 77,850 +12.8%
Value US$385,793
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.90
Quantity 100,000 +19.7%
Value US$490,000
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.81
Quantity 25,000 +5.2%
Value US$120,338
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
5.00
Quantity 20,000 +4.3%
Value US$100,000
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
5.00
Quantity 20,000 +4.5%
Value US$100,000
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.97
Quantity 50,000 +12.7%
Value US$248,615
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
5.00
Quantity 1,600 +0.4%
Value US$8,000
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
5.00
Quantity 1,810 +0.5%
Value US$9,050
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
4.95
Quantity 6,400 +1.7%
Value US$31,677
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
5.00
Quantity 7,798 +2.1%
Value US$38,985
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.80
Quantity 200 +0.0%
Value US$2,760
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.98
Quantity 10,000 +1.1%
Value US$139,822
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.98
Quantity 6,009 +0.7%
Value US$83,981
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.95
Quantity 200 +0.0%
Value US$2,790
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.80
Quantity 100 +0.0%
Value US$1,380
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
14.00
Quantity 75,178 +9.0%
Value US$1,052,492
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.80
Quantity 4,081 +0.5%
Value US$56,315
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.83
Quantity 800 +0.1%
Value US$11,063
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
14.00
Quantity 19,900 +2.5%
Value US$278,600
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
14.00
Quantity 25,000 +3.2%
Value US$350,000
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
14.00
Quantity 5,100 +0.7%
Value US$71,392
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
14.00
Quantity 35,101 +4.7%
Value US$491,260
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.97
Quantity 116,904 +18.6%
Value US$1,633,207
US Rallybio Corp (RLYB)
Transaction date
Purchase
Price
13.90
Quantity 3,900 +0.6%
Value US$54,201
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-02 2026-09-02
B Purchase
7,833 +5.1%
68.32
US$4,890,858 		7,833 +5.1% 68.32 US$4,890,858
2026-09-02 2026-09-01
B Purchase
11,730 +26.0%
120.47
US$4,152,692 		11,730 +26.0% 120.47 US$4,152,692
2026-09-02 2026-08-31
B Purchase
60,280 -20.3%
27.18
US$85,962 		60,280 -20.3% 27.18 US$85,962
2026-08-24 2026-08-24
B Purchase
107,374 +2.3%
1.75
US$188,355 		107,374 +2.3% 1.75 US$188,355
2026-08-24 2026-08-21
B Purchase
716,369 +17.8%
1.77
US$1,266,254 		716,369 +17.8% 1.77 US$1,266,254
2026-08-24 2026-08-20
B Purchase
202,124 +5.3%
1.78
US$359,538 		202,124 +5.3% 1.78 US$359,538
2026-08-03 2026-07-31
US NextCure Inc (NXTC)
B Purchase
8,003 +1.1%
4.80
US$38,414 		8,003 +1.1% 4.80 US$38,414
2026-08-03 2026-07-31
US NextCure Inc (NXTC)
B Purchase
25,000 +3.6%
4.98
US$124,540 		25,000 +3.6% 4.98 US$124,540
2026-08-03 2026-07-31
US NextCure Inc (NXTC)
B Purchase
3,300 +0.5%
4.98
US$16,420 		3,300 +0.5% 4.98 US$16,420
2026-08-03 2026-07-30
US NextCure Inc (NXTC)
B Purchase
77,850 +12.8%
4.96
US$385,793 		77,850 +12.8% 4.96 US$385,793
2026-08-03 2026-07-30
US NextCure Inc (NXTC)
B Purchase
100,000 +19.7%
4.90
US$490,000 		100,000 +19.7% 4.90 US$490,000
2026-08-03 2026-07-30
US NextCure Inc (NXTC)
B Purchase
25,000 +5.2%
4.81
US$120,338 		25,000 +5.2% 4.81 US$120,338
2026-08-03 2026-07-30
US NextCure Inc (NXTC)
B Purchase
20,000 +4.3%
5.00
US$100,000 		20,000 +4.3% 5.00 US$100,000
2026-08-03 2026-07-30
US NextCure Inc (NXTC)
B Purchase
20,000 +4.5%
5.00
US$100,000 		20,000 +4.5% 5.00 US$100,000
2026-08-03 2026-07-30
US NextCure Inc (NXTC)
B Purchase
50,000 +12.7%
4.97
US$248,615 		50,000 +12.7% 4.97 US$248,615
2026-07-29 2026-07-29
US NextCure Inc (NXTC)
B Purchase
1,600 +0.4%
5.00
US$8,000 		1,600 +0.4% 5.00 US$8,000
2026-07-29 2026-07-29
US NextCure Inc (NXTC)
B Purchase
1,810 +0.5%
5.00
US$9,050 		1,810 +0.5% 5.00 US$9,050
2026-07-29 2026-07-28
US NextCure Inc (NXTC)
B Purchase
6,400 +1.7%
4.95
US$31,677 		6,400 +1.7% 4.95 US$31,677
2026-07-29 2026-07-27
US NextCure Inc (NXTC)
B Purchase
7,798 +2.1%
5.00
US$38,985 		7,798 +2.1% 5.00 US$38,985
2026-07-17 2026-07-15
B Purchase
1,000 +0.1%
1.56
US$1,555 		1,000 +0.1% 1.56 US$1,555
2026-05-21 2026-05-19
B Purchase
200,000 +33.3%
1.50
US$299,800 		200,000 +33.3% 1.50 US$299,800
2026-05-21 2026-05-19
B Purchase
200,000 +50.0%
1.56
US$312,080 		200,000 +50.0% 1.56 US$312,080
2026-05-21 2026-05-19
B Purchase
68,551 +20.7%
1.60
US$109,668 		68,551 +20.7% 1.60 US$109,668
2026-05-20 2026-05-19
US Rallybio Corp (RLYB)
B Purchase
200 +0.0%
13.80
US$2,760 		200 +0.0% 13.80 US$2,760
2026-05-20 2026-05-19
US Rallybio Corp (RLYB)
B Purchase
10,000 +1.1%
13.98
US$139,822 		10,000 +1.1% 13.98 US$139,822
2026-05-20 2026-05-18
US Rallybio Corp (RLYB)
B Purchase
6,009 +0.7%
13.98
US$83,981 		6,009 +0.7% 13.98 US$83,981
2026-05-15 2026-05-15
US Rallybio Corp (RLYB)
B Purchase
200 +0.0%
13.95
US$2,790 		200 +0.0% 13.95 US$2,790
2026-05-15 2026-05-15
US Rallybio Corp (RLYB)
B Purchase
100 +0.0%
13.80
US$1,380 		100 +0.0% 13.80 US$1,380
2026-05-15 2026-05-13
US Rallybio Corp (RLYB)
B Purchase
75,178 +9.0%
14.00
US$1,052,492 		75,178 +9.0% 14.00 US$1,052,492
2026-05-15 2026-05-13
US Rallybio Corp (RLYB)
B Purchase
4,081 +0.5%
13.80
US$56,315 		4,081 +0.5% 13.80 US$56,315
2026-05-13 2026-05-12
US Rallybio Corp (RLYB)
B Purchase
800 +0.1%
13.83
US$11,063 		800 +0.1% 13.83 US$11,063
2026-05-13 2026-05-11
US Rallybio Corp (RLYB)
B Purchase
19,900 +2.5%
14.00
US$278,600 		19,900 +2.5% 14.00 US$278,600
2026-05-13 2026-05-11
US Rallybio Corp (RLYB)
B Purchase
25,000 +3.2%
14.00
US$350,000 		25,000 +3.2% 14.00 US$350,000
2026-05-13 2026-05-11
US Rallybio Corp (RLYB)
B Purchase
5,100 +0.7%
14.00
US$71,392 		5,100 +0.7% 14.00 US$71,392
2026-05-06 2026-05-05
US Rallybio Corp (RLYB)
B Purchase
35,101 +4.7%
14.00
US$491,260 		35,101 +4.7% 14.00 US$491,260
2026-05-06 2026-05-04
US Rallybio Corp (RLYB)
B Purchase
116,904 +18.6%
13.97
US$1,633,207 		116,904 +18.6% 13.97 US$1,633,207
2026-05-06 2026-05-04
US Rallybio Corp (RLYB)
B Purchase
3,900 +0.6%
13.90
US$54,201 		3,900 +0.6% 13.90 US$54,201
2025-10-15 2025-10-15
S Sale
743,358 -100.0%
17.75
US$13,194,604 		743,358 -100.0% 17.75 US$13,194,604
2025-10-15 2025-10-15
S Sale
254,669 -100.0%
17.75
US$4,520,375 		254,669 -100.0% 17.75 US$4,520,375
2025-10-15 2025-10-15
S Sale
4,391,237 -100.0%
17.75
US$77,944,457 		4,391,237 -100.0% 17.75 US$77,944,457
2025-04-11 2025-04-09
B Purchase
74,333 +1.7%
10.33
US$767,860 		74,333 +1.7% 10.33 US$767,860
2025-04-11 2025-04-09
B Purchase
500,000 +13.1%
10.33
US$5,165,000 		500,000 +13.1% 10.33 US$5,165,000
2025-04-11 2025-04-09
B Purchase
325,000 +9.3%
9.86
US$3,203,525 		325,000 +9.3% 9.86 US$3,203,525
2025-04-11 2025-04-09
B Purchase
16,365 +2.3%
9.40
US$153,752 		16,365 +2.3% 9.40 US$153,752
2025-04-11 2025-04-09
B Purchase
18,560 +0.5%
9.40
US$174,375 		18,560 +0.5% 9.40 US$174,375